Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de David Chang
Age : 61
Public asset : 80,312,987 USD
Country of residence : Unknown
Linked companies : Allogene Therapeutics, Inc. - Peloton Therapeutics, Inc.

Biography of David Chang 
Dr. David D. Chang is a President, Chief Executive Officer & Director at Allogene Therapeutics, Inc., a Director & Venture Partner at Vida Ventures LLC, a Venture Partner at Two River Consulting LLC, a Board Observer at Cell Design Labs, Inc., a Venture Partner at Two River Group Holdings LLC and a Venture Partner at VV Manager LLC. He is on the Board of Directors at Allogene Therapeutics, Inc., Peloton Therapeutics, Inc., Vida Ventures LLC, A2 Biotherapeutics, Inc. and IconOVir Bio, Inc. Dr. Chang was previously employed as a Chief Medical Officer, EVP-Research & Development by Kite Pharma, Inc., a Vice President-Global Development by Amgen, Inc., and an Associate Professor by David Geffen School of Medicine. He received his undergraduate degree from Massachusetts Institute of Technology and a doctorate degree from Stanford University.


Current positions of David Chang 
Holdings of David Chang 
David Chang : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/27ELON MUSK : human-like robots and self-driving cars
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/27BERNARD ARNAULT : LVMH has pricing power to counter inflation, but must be reasonable-Arnault
RE
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
RE
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
RE
01/28CATHIE WOOD : Cathie Wood's ARK buys the dip in Tesla shares after months of selling
RE
01/26WILLIAM ACKMAN : Ackman's Pershing Square takes new position in Netflix
RE
01/25JOHN HESS : Hess Corp sees higher capital spending, production in 2022
RE
More news


© 2022 People and Ownership :   
David Chang : Connections 


Latest news about David Chang 
2021Allogene Therapeutics Expands San Francisco Headquarters; Shares Rise Early
MT
2020PRESS RELEASE : ViGeneron and WuXi Advanced Therapies enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy
DJ
2020Global prospects dim for China's tech champions as great powers clash
T3
2020Global prospects dim for China's tech champions as great powers clash
RE
2020Global prospects dim for China's tech champions as great powers clash
T3
2020Global prospects dim for China's tech champions as great powers clash
T3
2020Global prospects dim for China's tech champions as great powers clash
T3
More news